Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg Sells 33,227 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 33,227 shares of the firm’s stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $0.81, for a total transaction of $26,913.87. Following the sale, the chief executive officer now owns 861,397 shares of the company’s stock, valued at approximately $697,731.57. The trade was a 3.71 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Leslie Trigg also recently made the following trade(s):

• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total value of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Trading Down 12.2 %

Shares of OM stock opened at $0.81 on Tuesday. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The stock has a market capitalization of $42.44 million, a price-to-earnings ratio of -0.29 and a beta of 2.05. The company’s fifty day simple moving average is $1.01 and its two-hundred day simple moving average is $1.41.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Huntington National Bank increased its stake in Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after acquiring an additional 20,000 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in shares of Outset Medical during the second quarter worth about $827,000. Squarepoint Ops LLC grew its holdings in shares of Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after purchasing an additional 34,187 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Outset Medical by 118.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock worth $5,925,000 after purchasing an additional 834,663 shares during the last quarter. Finally, National Bank of Canada FI raised its stake in Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares in the last quarter.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reissued a “sector perform” rating and issued a $3.00 price objective on shares of Outset Medical in a report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.